Yn dangos 106 i 120 o 463 canlyniadau
Performance review requirements 2023-24 - what to expect
We emailed education providers due their performance review in 2023-24 in late June. Providers who will undergo the process this year (2023-24) will have been given specific requirements and a key contact to work with at the HCPC.
Quarterly direct debits available from this summer
We are introducing this change following feedback from registrants that more regular payments would help registrants to spread the cost more evenly across the year.
What our Fitness to practise annual report shows
The level of public concern in our professions remains small, but it is rising
HCPC and health regulators' joint statement supports reflective practice across healthcare
Nine healthcare regulators, including the HCPC, have signed a joint statement outlining the processes and advantages of good reflective practice
A review of our education outcomes for the academic year
We have looked back on our approval and monitoring outcomes from the last academic year
Adding your NI number to the Partner Portal
Use our step-by-step guide to enter your national insurance number into the Partner Portal
Launch of consultation for the standards of conduct, performance and ethics
Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.
Learning from our data – what 2020-21 taught us
Insights into the 2020-21 education dataset.
HCPC response to DHSC healthcare regulation consultation
As we move forward with the wider programme of regulatory reform, we welcome this consultation to consider how the powers to introduce and remove professions from regulation might be used in the future.
HCPC responds to the Government’s regulatory reform consultation
“An important step towards modernising and reforming professional regulation”
Chiropodists, podiatrists and hearing aid dispensers renewal window closing soon
The deadline for chiropodists, podiatrists and hearing aid dispensers to complete their registration renewal is fast approaching
Reclassification of Gabapentin and Pregabalin
From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)